#pharmaceutical

#pharmaceutical

Eli Lilly aims to become the first healthcare company with a $1 trillion market cap, spurred by its GLP-1 therapy leadership.

Orforglipron's success in trials positions Lilly for significant market growth in obesity and diabetes management.

The UK's life sciences sector is losing £15 billion annually due to reduced investment and exports.

Pharmacy packaging is undergoing a digital transformation, enhancing safety, efficiency, and compliance through innovations like smart packaging and child-resistant designs.